These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 16793948

  • 1. The reduction of bone mineral density in postmenopausal women with primary hyperparathyroidism is higher in the presence of concomitant GH secretion impairment.
    Cecconi E, Gasperi M, Genovesi M, Bogazzi F, Grasso L, Cetani F, Procopio M, Marcocci C, Bartalena L, Martino E.
    Eur J Endocrinol; 2006 Jul; 155(1):41-5. PubMed ID: 16793948
    [Abstract] [Full Text] [Related]

  • 2. Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism.
    Colao A, Di Somma C, Pivonello R, Loche S, Aimaretti G, Cerbone G, Faggiano A, Corneli G, Ghigo E, Lombardi G.
    J Clin Endocrinol Metab; 1999 Jun; 84(6):1919-24. PubMed ID: 10372687
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of growth hormone secretion in mild primary hyperparathyroidism.
    Coiro V, Volpi R, Capretti L, Finardi L, Magotti MG, Manfredi G, Chiodera P, Saccani Jotti G.
    Horm Res; 2004 Jun; 62(2):88-91. PubMed ID: 15249740
    [Abstract] [Full Text] [Related]

  • 4. GH secretion is impaired in patients with primary hyperparathyroidism.
    Gasperi M, Cecconi E, Grasso L, Bartalena L, Centoni R, Aimaretti G, Broglio F, Miccoli P, Marcocci C, Ghigo E, Martino E.
    J Clin Endocrinol Metab; 2002 May; 87(5):1961-4. PubMed ID: 11994325
    [Abstract] [Full Text] [Related]

  • 5. Primary hyperparathyroidism is associated with marked impairment of GH response to acylated ghrelin.
    Cecconi E, Bogazzi F, Morselli LL, Gasperi M, Procopio M, Gramaglia E, Broglio F, Giovannetti C, Ghigo E, Martino E.
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):197-201. PubMed ID: 18221398
    [Abstract] [Full Text] [Related]

  • 6. The growth hormone (GH) response to the arginine plus GH-releasing hormone test is correlated to the severity of lipid profile abnormalities in adult patients with GH deficiency.
    Colao A, Cerbone G, Pivonello R, Aimaretti G, Loche S, Di Somma C, Faggiano A, Corneli G, Ghigo E, Lombardi G.
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1277-82. PubMed ID: 10199767
    [Abstract] [Full Text] [Related]

  • 7. Bone turnover and mineral density in adult thalassemic patients: relationships with growth hormone secretory status and circulating somatomedins.
    Scacchi M, Danesi L, Cattaneo A, Sciortino G, Radin R, Ambrogio AG, Vitale G, D'Angelo E, Mirra N, Zanaboni L, Arvigo M, Boschetti M, Ferone D, Marzullo P, Baldini M, Cassinerio E, Cappellini MD, Persani L, Cavagnini F.
    Endocrine; 2016 Aug; 53(2):551-7. PubMed ID: 26825070
    [Abstract] [Full Text] [Related]

  • 8. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial.
    Lips P, Duong T, Oleksik A, Black D, Cummings S, Cox D, Nickelsen T.
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1212-21. PubMed ID: 11238511
    [Abstract] [Full Text] [Related]

  • 9. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
    Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD.
    J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
    [Abstract] [Full Text] [Related]

  • 10. Improvement of growth hormone deficiency in patients with primary hyperparathyroidism after parathyroidectomy: results of a prospective study.
    Cecconi E, Gasperi M, Bogazzi F, Grasso L, Genovesi M, Marcocci C, Pinchera A, Procopio M, Bartalena L, Martino E.
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1213-6. PubMed ID: 15001612
    [Abstract] [Full Text] [Related]

  • 11. Retesting young adults with childhood-onset growth hormone (GH) deficiency with GH-releasing-hormone-plus-arginine test.
    Aimaretti G, Baffoni C, Bellone S, Di Vito L, Corneli G, Arvat E, Benso L, Camanni F, Ghigo E.
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3693-9. PubMed ID: 11061526
    [Abstract] [Full Text] [Related]

  • 12. Relationship between the morphological evaluation of the pituitary and the growth hormone (GH) response to GH-releasing hormone Plus arginine in children and adults with congenital hypopituitarism.
    Maghnie M, Salati B, Bianchi S, Rallo M, Tinelli C, Autelli M, Aimaretti G, Ghigo E.
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1574-9. PubMed ID: 11297586
    [Abstract] [Full Text] [Related]

  • 13. Bone demineralization in adult thalassaemic patients: contribution of GH and IGF-I at different skeletal sites.
    Scacchi M, Danesi L, Cattaneo A, Valassi E, Pecori Giraldi F, Argento C, D'Angelo E, Mirra N, Carnelli V, Zanaboni L, Tampieri B, Cappellini MD, Cavagnini F.
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):202-7. PubMed ID: 18221395
    [Abstract] [Full Text] [Related]

  • 14. Low dose hexarelin and growth hormone (GH)-releasing hormone as a diagnostic tool for the diagnosis of GH deficiency in adults: comparison with insulin-induced hypoglycemia test.
    Gasperi M, Aimaretti G, Scarcello G, Corneli G, Cosci C, Arvat E, Martino E, Ghigo E.
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2633-7. PubMed ID: 10443652
    [Abstract] [Full Text] [Related]

  • 15. [Growth hormone deficiency, its influence on bone mineral density and risk of osteoporotic fractures].
    Kuzma M, Payer J.
    Cas Lek Cesk; 2010 Aug; 149(5):211-6. PubMed ID: 20629339
    [Abstract] [Full Text] [Related]

  • 16. Elderly patients with adult-onset growth hormone deficiency are not osteopenic.
    Toogood AA, Adams JE, O'Neill PA, Shalet SM.
    J Clin Endocrinol Metab; 1997 May; 82(5):1462-6. PubMed ID: 9141534
    [Abstract] [Full Text] [Related]

  • 17. The impact of idiopathic childhood-onset growth hormone deficiency (GHD) on bone mass in subjects without adult GHD.
    Lange M, Müller J, Svendsen OL, Kastrup KW, Juul A, Feldt-Rasmussen U.
    Clin Endocrinol (Oxf); 2005 Jan; 62(1):18-23. PubMed ID: 15638865
    [Abstract] [Full Text] [Related]

  • 18. Growth hormone secretion in primary and secondary hyperparathyroidism.
    Cecconi E, Gasperi M, Genovesi M, Bogazzi F, Grasso L, Procopio M, Marcocci C, Pinchera A, Bartalena L, Martino E.
    J Endocrinol Invest; 2005 Feb; 28(2):113-6. PubMed ID: 15887855
    [Abstract] [Full Text] [Related]

  • 19. The natural history of partial growth hormone deficiency in adults: a prospective study on the cardiovascular risk and atherosclerosis.
    Colao A, Di Somma C, Spiezia S, Rota F, Pivonello R, Savastano S, Lombardi G.
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2191-200. PubMed ID: 16537686
    [Abstract] [Full Text] [Related]

  • 20. Impact of growth hormone status on body composition and the skeleton.
    Mukherjee A, Murray RD, Shalet SM.
    Horm Res; 2004 Jun; 62 Suppl 3():35-41. PubMed ID: 15539797
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.